Yi-Ming Chen Selected Research

Succinate-CoA Ligases (Succinyl Coenzyme A Synthetases)

1/2022

Novel compound heterozygous SUCLG1 variants may contribute to mitochondria DNA depletion syndrome-9.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yi-Ming Chen Research Topics

Disease

43	Rheumatoid Arthritis 01/2021 - 01/2009
16	Infections 12/2021 - 01/2007
12	Inflammation (Inflammations) 01/2022 - 02/2011
12	Fatigue 04/2020 - 03/2014
11	Adult-Onset Still's Disease 02/2022 - 10/2009
11	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 12/2010
9	Neoplasms (Cancer) 01/2019 - 12/2010
8	Arthritis (Polyarthritis) 05/2022 - 10/2009
8	Diabetes Mellitus 01/2020 - 12/2009
7	Necrosis 11/2021 - 02/2011
7	Tuberculosis (Tuberculoses) 01/2017 - 02/2012
6	Hyperlipidemias (Hyperlipidemia) 12/2021 - 11/2011
5	Ankylosing Spondylitis 01/2022 - 11/2015
5	Hepatitis 01/2022 - 10/2018
4	Stroke (Strokes) 01/2022 - 12/2009
4	Autoimmune Diseases (Autoimmune Disease) 04/2021 - 10/2013
4	Hypertension (High Blood Pressure) 01/2021 - 09/2013
4	Hepatitis B 06/2019 - 10/2011
4	Acquired Immunodeficiency Syndrome (AIDS) 02/2018 - 07/2006
3	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2022 - 01/2017
3	Lupus Nephritis 01/2022 - 09/2016
3	Nephritis 01/2022 - 09/2016
3	Rheumatic Diseases (Rheumatism) 07/2021 - 03/2015
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 01/2016
3	Atherosclerosis 12/2020 - 03/2015
3	Insulin Resistance 12/2020 - 03/2015
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2020 - 04/2008
3	Periodontitis 01/2020 - 07/2013
3	Experimental Arthritis 12/2017 - 12/2015
3	Hepatocellular Carcinoma (Hepatoma) 02/2014 - 05/2011
2	Myocardial Infarction 01/2022 - 01/2021
2	Osteoporosis 12/2021 - 11/2011
2	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 11/2021 - 02/2020

Drug/Important Bio-Agent (IBA)

15	CytokinesIBA 01/2020 - 01/2009
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2009
9	Pharmaceutical PreparationsIBA 12/2021 - 01/2014
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2012
9	Biological ProductsIBA 01/2021 - 12/2014
9	AmmoniaIBA 04/2020 - 03/2014
9	Lactic Acid (Lactate)FDA LinkGeneric 04/2020 - 03/2014
8	Interleukin-6 (Interleukin 6)IBA 12/2020 - 01/2009
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 07/2011
7	Interleukin-17 (Interleukin 17)IBA 11/2021 - 07/2011
7	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 01/2016
7	Creatine Kinase (Creatine Phosphokinase)IBA 04/2020 - 03/2014
7	Adalimumab (Humira)FDA Link 01/2020 - 03/2015
6	Antirheumatic Agents (DMARD)IBA 01/2021 - 01/2016
6	Etanercept (Enbrel)FDA Link 01/2016 - 12/2013
5	oxidized low density lipoproteinIBA 01/2021 - 05/2015
5	NitrogenIBA 04/2020 - 01/2016
5	Urea (Carbamide)FDA LinkGeneric 04/2020 - 01/2016
5	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 01/2011
5	AntibodiesIBA 10/2019 - 09/2009
5	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 03/2014
4	tocilizumab (atlizumab)FDA Link 02/2022 - 01/2017
4	EnzymesIBA 10/2021 - 08/2014
4	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021 - 07/2015
4	Triglycerides (Triacylglycerol)IBA 01/2021 - 12/2009
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 12/2010
4	Phosphotransferases (Kinase)IBA 10/2019 - 10/2011
4	Rituximab (Mabthera)FDA Link 06/2019 - 04/2013
4	GlycogenIBA 05/2019 - 01/2016
4	Isoniazid (Ftivazide)FDA LinkGeneric 02/2019 - 02/2012
4	ORALIT (ORS)IBA 01/2019 - 07/2013
4	AntigensIBA 01/2018 - 12/2010
4	CholesterolIBA 03/2016 - 12/2009
3	CreatinineIBA 01/2022 - 01/2020
3	InterferonsIBA 01/2022 - 02/2012
3	MicroRNAs (MicroRNA)IBA 12/2021 - 01/2018
3	Complement System Proteins (Complement)IBA 11/2021 - 09/2016
3	ImmunosorbentsIBA 10/2021 - 08/2014
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 07/2021 - 10/2011
3	LipidsIBA 01/2021 - 12/2009
3	Anti-Citrullinated Protein AntibodiesIBA 01/2021 - 09/2009
3	LDL CholesterolIBA 01/2021 - 05/2015
3	tofacitinibIBA 10/2020 - 01/2018
3	Blood Glucose (Blood Sugar)IBA 04/2020 - 07/2018
3	Folic Acid (Vitamin M)FDA LinkGeneric 01/2020 - 05/2011
3	GlucocorticoidsIBA 01/2017 - 07/2015
3	Hemoglobins (Hemoglobin)IBA 12/2016 - 11/2010
3	lardIBA 03/2016 - 05/2015
3	GoldIBA 01/2016 - 02/2012
3	Rheumatoid FactorIBA 03/2015 - 09/2009
3	C-Reactive ProteinIBA 09/2014 - 01/2011
3	Immunoglobulin M (IgM)IBA 01/2014 - 08/2010
3	Immunoglobulin G (IgG)IBA 01/2014 - 08/2010
2	Dextromethorphan (Racemethorphan)FDA LinkGeneric 05/2022 - 12/2017
2	Therapeutic UsesIBA 05/2022 - 10/2016
2	Interleukin-18 (Interleukin 18)IBA 02/2022 - 10/2009
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2022 - 11/2021
2	AutoantibodiesIBA 12/2021 - 11/2021
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2021 - 01/2021
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2021 - 04/2020
2	Uric Acid (Urate)IBA 11/2021 - 01/2021
2	Antinuclear AntibodiesIBA 11/2021 - 04/2021
2	anti-dsDNA autoantibodyIBA 10/2021 - 09/2016
2	SteroidsIBA 07/2021 - 01/2018

Therapy/Procedure

21	Therapeutics 05/2022 - 07/2010
7	Biological Therapy 01/2022 - 03/2015
2	Oral Administration 05/2022 - 04/2016